Jenburkt Pharma Corporate Action

Jenburkt Pharma

Data will be updated when it becomes available.


Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
Corporate Action

Action :

From Date:

To Date:

PurposeAGM DateAnnouncement DateBook Closure Start DateBook Closure End Date
AGM26-Jul-202323-May-2023--
The Board of Directors of the Company, at their meeting held on 23rd May, 2023, fixed the book closure date starting from Thursday, 20th July, 2023 to Wednesday, 26th July, 2023 (both days inclusive) for the purpose of payment of dividend, as recommended in the same meeting. The Board has also, fixed the cut-off date as Wednesday, 19th July, 2023, for the purpose of determining the eligibility of Shareholders eligible for remote e-voting or e-voting during the 38th AGM, scheduled on Wednesday, 26th July, 2023. Pursuant to regulation 30 of the SEBI-LODR, we enclosed copies of advertisement published in newspapers viz. The Free Press Journal (English) and Navshakti (Marathi) on 01st July, 2023, respectively, regarding Notice of the 38th Annual General Meeting of the Members of the Company. (As Per BSE Announcement Dated on 01.07.2023) JENBURKT PHARMACEUTICALS LIMITED has informed BSE about Notice of Shareholders Meeting for Annual General Meeting. (As Per BSE Announcement Dated on 05.07.2023) Announcement under Regultion 30 (LODR)-proceedings of the 38th AGM of the Company held today, i.e. 26th July, 2023, through VC/OAVM. (As per BSE Announcement Dated on 26/07/2023) Appointment of an independent and non-executive director viz. Sumit A. Thakkar, at the 38th AGM of the Company held on 26.07.2023 (As Per BSE Announcement dated on 27.07.2023)